Reversal of Small, Dense LDL Subclass Phenotype by Normalization of Adiposity

被引:29
作者
Siri-Tarino, Patty W. [1 ]
Williams, Paul T. [2 ]
Fernstrom, Harriet S. [1 ]
Rawlings, Robin S. [1 ]
Krauss, Ronald M. [1 ]
机构
[1] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
[2] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Dept Genome Sci, Berkeley, CA 94720 USA
基金
美国国家卫生研究院;
关键词
CORONARY-HEART-DISEASE; LIPOPROTEIN CHOLESTEROL LEVELS; SET-POINT THEORY; WEIGHT-LOSS; LOW-FAT; INSULIN-RESISTANCE; METABOLIC SYNDROME; LOW-CARBOHYDRATE; PARTICLE-SIZE; RISK;
D O I
10.1038/oby.2009.146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Excess adiposity and high-carbohydrate diets have been associated with an atherogenic lipoprotein phenotype (ALP) characterized by increased concentrations of small, dense low-density lipoprotein (LDL) particles (pattern B). We tested whether weight loss and normalization of adiposity could reverse ALP in overweight men with pattern B. After consuming a moderate-carbohydrate, high-fat diet for 3 weeks, pattern B and nonpattern B (pattern A) men were randomized to a weight loss (n = 60 and n = 36, respectively) or control weight-stable arm (n = 20 and n = 17, respectively). Men in the weight loss arm consumed similar to 1,000 fewer calories per day over 9 weeks to induce an average similar to 9kg weight loss. In the control group, weight stability was maintained for 4 weeks after randomization. Weight loss led to the conversion of pattern B to pattern A in 58% of baseline pattern B men. Among men who achieved BMIs of <25kg/m(2) (62% of pattern B men vs. 83% of pattern A men), 81% of pattern B men converted to pattern A. Weight loss was associated with a significantly greater decrease in small, dense LDL subclass 3b in pattern B relative to pattern A men. The lipoprotein profiles of pattern A men who converted from pattern B were comparable to those of men with pattern A at baseline. Conversion of LDL subclass pattern B to pattern A and reversal of ALP can be achieved in a high proportion of overweight men by normalization of adiposity.
引用
收藏
页码:1768 / 1775
页数:8
相关论文
共 32 条
[1]   GENETICS OF LDL SUBCLASS PHENOTYPES IN WOMEN TWINS - CONCORDANCE, HERITABILITY, AND COMMINGLING ANALYSIS [J].
AUSTIN, MA ;
NEWMAN, B ;
SELBY, JV ;
EDWARDS, K ;
MAYER, EJ ;
KRAUSS, RM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (05) :687-695
[2]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[3]   LDL PARTICLE-SIZE DISTRIBUTION - RESULTS FROM THE FRAMINGHAM OFFSPRING STUDY [J].
CAMPOS, H ;
BLIJLEVENS, E ;
MCNAMARA, JR ;
ORDOVAS, JM ;
POSNER, BM ;
WILSON, PWF ;
CASTELLI, WP ;
SCHAEFER, EJ .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (12) :1410-1419
[4]   NUTRIENT INTAKE COMPARISONS BETWEEN FRAMINGHAM AND RURAL AND URBAN PURISCAL, COSTA-RICA - ASSOCIATIONS WITH LIPOPROTEINS, APOLIPOPROTEINS, AND LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE [J].
CAMPOS, H ;
WILLETT, WC ;
PETERSON, RM ;
SILES, X ;
BAILEY, SM ;
WILSON, PWF ;
POSNER, BM ;
ORDOVAS, JM ;
SCHAEFER, EJ .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (04) :1089-1099
[5]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[6]   Abdominal obesity and the metabolic syndrome:: Contribution to global cardiometabolic risk [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle ;
Bergeron, Jean ;
Pibarot, Philippe ;
Mathieu, Patrick ;
Larose, Eric ;
Rodes-Cabau, Josep ;
Bertrand, Olivier F. ;
Poirier, Paul .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) :1039-1049
[7]   LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women [J].
Dreon, DM ;
Fernstrom, HA ;
Williams, PT ;
Krauss, RM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) :707-714
[8]  
Dreon DM, 2000, AM J CLIN NUTR, V71, P1611
[9]  
Enas Enas A, 2007, J Cardiometab Syndr, V2, P267, DOI 10.1111/j.1559-4564.2007.07392.x
[10]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499